mitoxantrone Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (1)

Phase 3 (1)

Interventional (1)

Children's Oncology Group (1)

No (1)

No (1)

Adult (18+) (1)
Pediatric (Under 18) (1)

I am/have/had

I am/have/hadcancer

I am/have/hadleukemia

I am/have/hadacute myeloid leukemia

I am/have/hadmyeloid leukemia

I am/have/hadblast count

I am/have/hadwhite blood cell count

I am/have/hadflt3 gene

I am/have/hadblood count

I am/have/hadresidual leukemic cells

I am/have/hadfibrosis

I am/have/hadblast cells

I am/have/hadneuropsychological testing

I am/have/hadheart problems

I am/have/hadvision test

I am/have/hadcongenital heart block

I am/have/hadcell transplantation

I am/have/hadallogeneic hematopoietic stem cell transplant

I am/have/haddown syndrome

I am/have/hadleukemic cells

I am/have/hadwilliams syndrome

added new label for I am/have/had

more

I am looking for

I am looking formitoxantrone

I am looking forcytarabine

I am looking foretoposide

I am looking foranthracyclines

I am looking fordaunorubicin

I am looking formethotrexate

I am looking forcytarabine/daunorubicin

I am looking forgemtuzumab ozogamicin

I am looking forgemtuzumab

I am looking forgilteritinib

I am looking forchemotherapy drug

I am looking foranthracycline

added new label for I am looking for

more

Advanced Filters

Loading...

Found 1 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 3
For pediatric ages
For adults
Recruiting in 1000s
Interventional Study
all
Hematology
Recruiting

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

This phase III trial compares standard chemotherapy to therapy with CPX-351 and/or gilteritinib for patients with newly diagnosed acute myeloid leukemia with or without FLT3 mutations. Drugs used in chemotherapy, such as daunorubicin, cytarabine, and gemtuzumab ozogamicin, work in different ways to stop the growth of cancer cells, either by …

acute myeloid leukemia

heart problems

allogeneic hematopoietic stem cell transplant

williams syndrome

gilteritinib

0 views
2 annotations
19 Feb, 2024

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2024 All rights reserved.